Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

February 15, 2011; 76 (7 Supplement 2) Articles

Driving and Neurologic Disorders

Joseph F. Drazkowski, Joseph I. Sirven
First published February 14, 2011, DOI: https://doi.org/10.1212/WNL.0b013e31820c360c
Joseph F. Drazkowski
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph I. Sirven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Driving and Neurologic Disorders
Joseph F. Drazkowski, Joseph I. Sirven
Neurology Feb 2011, 76 (7 Supplement 2) S44-S49; DOI: 10.1212/WNL.0b013e31820c360c

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
3354

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure An evidence-based algorithm to help clinicians decide when a patient with cognitive impairment should not drive

    CDR = Clinical Dementia Rating; DMV = Department of Motor Vehicles; MMSE = Mini-Mental State Examination. Reprinted with permission from Iverson D, Gronseth G, Reger M, et al. Practice parameter update: evaluation and management of driving risk in dementia. Neurology 2010;74:1316–1324.5

Tables

  • Figures
  • Table 1
  • Table 2
  • Table 3
  1. Joseph F. Drazkowski, MD and
  2. Joseph I. Sirven, MD
  1. From the Department of Neurology, Mayo Clinic in Arizona, Phoenix.
  1. Address correspondence and reprint requests to Dr. Joseph I. Sirven, Department of Neurology, Mayo Clinic in Arizona, 5777 East Mayo Boulevard, Phoenix, AZ 85054; sirven.joseph{at}mayo.edu
Figure

Automobile driving is an indispensable activity of daily life. Driving in the United States equates to independence, freedom, and, in most cases, economic livelihood. Yet vehicular crashes injure millions of people in the United States each year at a cost of more than $250 billion, resulting in 40,000 annual deaths.1 Many medical, neurologic, and psychiatric disorders can impair the ability to drive. In particular, conditions such as Alzheimer disease (AD), Parkinson disease (PD), illicit drug use, multiple sclerosis (MS), cerebrovascular disease, sleep disorders, and epilepsy may impair an individual to the point of affecting the safe operation of a motor vehicle. Therefore, the issue of driving is significant for patients, physicians, and the public. Two common questions regarding driving typically arise during a neurologic consultation: When should driving be curtailed? When should a physician report an individual to a public driving authority to terminate their driving privileges? Driving is both a personal and public health issue mired in regulatory and legal language; therefore, it is essential to understand the variables that have an impact on driving.

THE NEUROLOGY OF DRIVING

Driving is a deceptively complex task. To effectively drive an automobile, a number of neurologic systems must be intact. These include higher cognitive functioning, vision, motor control, intact coordination, and an ability to maintain attention. Any functional impairment in any of these domains can potentially lead to unsafe driving. Table 1 summarizes examples of common neurologic impairment and paroxysmal conditions that can affect safe driving. Any patient with a neurologic condition containing an impairment listed in table 1 should alert the neurologist that driving should be addressed with the patient during the consultation. The presence of either a neurologic deficit or paroxysmal condition does not automatically exclude driving. It is the degree of deficit, frequency, and type of events that determines fitness for driving.

View this table:
Table 1

Neurologic impairments and paroxysmal disorders that may affect safe driving

Of the various neurologic systems involved in driving, cognitive function merits particular attention. Driving requires a number of essential cognitive activities for safe and successful vehicle operation. These cognitive activities include the following:

  • Perception and attention to stimulus evidence through sensory input and interpretation of a situation on the road

  • Formulation of a plan based on the particular driving situation and how to handle it based on previous memory experiences

  • Execution of an action such as applying a brake, steering control, or accelerator

  • Monitoring the outcome of a behavior as feedback for subsequent actions

The risk of driving error increases when there is any deficit in the ability to process these various tasks2 (table 2). Therefore, pathology that affects attention, perception, executive and motor function, and awareness of cognition and behavioral performance may lead to driving errors resulting in a crash. Additionally, individuals with problems in these domains are less likely to be aware of their deficits and errors and self-monitor resulting in the inability to perform appropriate corrective actions.

View this table:
Table 2

Cognitive impairments and impact on driving

“Although a clinician is likely able to identify obviously impaired drivers, a clinician's assessment alone may not be accurate enough to determine driving competency in drivers marginally affected by neurologic disorders”

Establishing fair and accurate performance criteria to predict ability to drive in patients with various neurologic conditions may reduce the risk of motor vehicle crashes and protect others from arbitrary and possibly unfair licensing revocation. Although a clinician is likely able to identify obviously impaired drivers, a clinician's assessment alone may not be accurate enough to determine driving competency in drivers marginally affected by neurologic disorders. For example, a patient with mild cognitive impairment (MCI) as defined by a Clinical Dementia Rating (CDR) score of 0.5 may or may not perform well on driving tasks. The same is true of paroxysmal conditions like epilepsy. The type and degree of cognitive and visual motor impairment are better predictors of driving skills than age or medical diagnoses.

The signs and symptoms of many neurologic conditions with unique neuropathological findings often demonstrate considerable overlap. Thus, a discussion of driving and neurologic disorders is best served by operating on a practical framework that clinicians are likely to encounter while patients are being actively evaluated for a final diagnosis. Neurologic diseases can be broadly classified into those associated with fixed deficits (i.e., neurodegenerative and stroke) or paroxysmal disorders (i.e., epilepsy and sleep disorders). This division of neurologic disorders allows the clinician to extrapolate applicable information to help counsel the individual patient regardless of the underlying neurologic process. Because epilepsy and dementia are explicitly cited by legal statutes (all 50 states for epilepsy; 2 states for dementia) (table 3), these 2 conditions serve as representative examples.

View this table:
Table 3

State driving laws

FIXED DEFICIT DISORDERS: AD

AD is one of the most common forms of dementia with increased prevalence with older age. Because AD leads to cognitive impairment, which affects executive function, and memory, driving is a major issue. A survey of patients with AD showed a mean of 0.09 reported crashes per year per person, compared with 0.040 in age-matched controls over the same time period.3 The average number of crashes per year in patients with AD increased dramatically after the first 3 years from symptom onset, consistent with other reports showing a sharp decline in driving abilities 3 years after AD onset.

An American Academy of Neurology (AAN) review panel found that drivers with MCI or very mild AD and a CDR score of 0.5 have impairment similar to drivers 16–20 years of age or those driving under the influence of alcohol at a blood alcohol concentration of less than 0.08%.8 The panel recommended reassessing dementia severity in driving fitness every 6 months in patients with very mild AD, but suspending driving for patients with mild AD and CDR score of 1 because of a history of increased crashes and poor driving performance.4 However, this recommendation may be unduly restrictive because in some ways it is a one-size-fits-all approach.

Recently, the AAN released a practice parameter update entitled “Evaluation and management of driving risk in dementia: Report of the Quality Standards Subcommittee of the American Academy of Neurology.”5 The parameter was helpful in that it coalesced a number of risk factors into a proposed evaluation algorithm (figure).5 Yet the parameter is far from being the final word on the topic. There was no evidence to support or refute the use of cognitive tests in making driving determinations, which is problematic as they are used to track progression of these conditions. Patients scoring at a higher risk may agree to surrender driving privileges. Patients who insist on continued driving may require an assessment by trained clinicians who conduct driving evaluations and retraining of patients with impairments (commonly poststroke or traumatic brain injury). The Association for Driver Rehabilitation Specialists, a professional organization of clinicians working in the field of driver education and training, information referral source, and specialized transportation equipment for disabled persons, may serve as a potential resource for neurologists looking for help in assessing individual patients. Referral to a health professional involved in driving assessments may help provide objective information needed to make difficult decisions. Patients who continue to drive despite progressive neurologic deficits should be reassessed every 6 months.

Figure
Figure An evidence-based algorithm to help clinicians decide when a patient with cognitive impairment should not drive

CDR = Clinical Dementia Rating; DMV = Department of Motor Vehicles; MMSE = Mini-Mental State Examination. Reprinted with permission from Iverson D, Gronseth G, Reger M, et al. Practice parameter update: evaluation and management of driving risk in dementia. Neurology 2010;74:1316–1324.5

There is also considerable ongoing research utilizing driving simulation to accurately identify at-risk drivers and is based on simulator performance. These studies have not been validated to assess whether simulation tasks are predictive of increased crash rates. Moreover, these simulators are not readily available for widespread clinical use. However, they may prove to be the future for helping clinicians to decide which patients should stop driving.

Regarding other neurologic conditions with fixed deficits, there is considerable ongoing research but no practice parameters or guidelines on when to restrict driving for common conditions including MS, PD, stroke, and others. Nevertheless, the principles used to make decisions regarding driving and AD are applicable to these conditions as well.

PAROXYSMAL CONDITIONS: EPILEPSY

The ability to legally operate a motor vehicle has been shown to be very important for the person with a paroxysmal disorder such as epilepsy or syncope.6 Driving has an impact on the quality of life for these patients. As opposed to other neurologic conditions, all states within the United States have laws that specifically address the ability to operate a motor vehicle for the person with epilepsy. However, among the various states, there is considerable legal variability as to the degree of seizure freedom one must exhibit in order to drive, with seizure-free intervals (SFI) ranging from 3 months to up to 1 year. Recommendations by the Epilepsy Foundation of America, American Academy of Neurology, and the International League Against Epilepsy have suggested standardized criteria be used when establishing laws that govern seizures and driving. Driving laws remain states' rights and not a federal issue, accounting for the heterogeneous approach to policy.7,8

The intent of laws governing the person with epilepsy (PWE) who drives is to ensure the public safety foremost with the secondary duty of protecting the individual driver. The optimal SFI that would allow the person with epilepsy to drive while at the same time ensuring public safety is not certain. Little difference in epilepsy-related crash rates has been found when comparing a reduction in the SFI from 12 to 3 months in Arizona.9 The overall death rate attributable to motor vehicle crashes related to a seizure has also been shown not to be dependent on the length of the SFI.9

Web sites from the American Medical Association and the Epilepsy Foundation of America are important resources listing current state laws regarding driving and epilepsy.7,8 These references compile information about local laws to help guide and counsel the PWE about relevant restrictions on driving. Several states have reporting requirements, where the individual practitioner must notify the driving authorities when a person has the diagnosis of epilepsy or other paroxysmal conditions as listed in table 3. Unfortunately, this places the reporting requirements on the practitioner providing care for the PWE, potentially interfering with optimal care, as the PWE may withhold vital information regarding recurrence and frequency of seizures in an effort to maintain driving privileges.

When comparing the various crash rates to other medical conditions that could affect driving, epilepsy has been shown to present the same relative risk as many other medical conditions. Many other medical conditions do not have specific restrictions against driving despite similar or higher risk of causing a crash. Paroxysmal disorders that are often not explicitly cited in driving laws include narcolepsy, syncope, and excessive daytime sleepiness. The PWE may have similar defined risk, but it should be noted that laws specifically mention seizures and therefore by nature will be more restrictive to keeping PWE off the road when compared to people with other medical conditions. The potential consequences of driving illegally are considerable, ranging from death and self-injury of the driver or a person at large to potential civil or criminal litigation. If a PWE knowingly drives illegally and causes a crash with injury to another due to a seizure, criminal prosecution is possible.

There are limited specific exceptions in some locales allowing PWE continue to drive despite still having seizures; these vary by state. Epilepsy advocacy groups have suggested specific exemptions be incorporated into driving regulations for PWE, such as 1) an established pattern of exclusively nocturnal seizures; 2) seizures with a consistent aura of sufficient length to allow the operator to safely stop the vehicle; and 3) breakthrough seizures due to nonrecurrent events (illness or medication change, where typically a shorter SFI is suggested). Not all states have these exemptions.

Most individuals are covered under noncommercial license laws. However, if an individual has the requirement to chauffeur or operate a motor vehicle carrying passengers, or drives a commercial vehicle (both interstate and interstate), commercial driving laws apply. Similarly, a person driving large commercial trucks across state lines must follow federal laws regulated by the US Department of Transportation.7 Commercial driving laws are typically more restrictive in that PWE and other applicable neurologic conditions cannot hold a commercial license. Additionally, the use of epilepsy medications, even when used for other medical conditions, will often restrict a commercial license.

COUNSELING A NEUROLOGY PATIENT REGARDING DRIVING

Most health care practitioners have little or no training in medico-legal issues although counseling on these issues typically is done by practitioners. Driving with any health condition has legal implications. The discussion with the patient should be frank and honest, and known facts reviewed using many of the points previously discussed.10 The practitioner may be conflicted in a situation where he or she suspects the individual is driving against advice. Many, but not all, states allow the practitioner to report such situations to driving authorities with immunity, to ensure public safety, specifically when reported in good faith. Practitioners can remind the driver that he or she is not immune from civil and possibly criminal prosecution if illegal driving continues. Additionally, it is important to inform the patient that auto insurance may not apply if it is determined that the person is driving illegally.

Using these discussion points provides the patient and practitioner with the basis for appropriate decisions. Nevertheless, discussions on driving are often quite challenging, even adversarial, as the patient sees such restrictions as a loss of personal freedom. As with many decisions regarding health care, the health care provider should be an advocate, which sometimes means no driving. The provider should commit to a relationship with the patient and advise him or her based on the individual facts and circumstances of the case. The discussion requires that the health provider understand local and possibly federal driving laws. Oftentimes, when the facts are explained, the patient generally follows a prudent course of action. Framing the discussion on a personal level and reminding the individual of the consequences of causing injury or death to another driver, bystander, passenger, or themselves often helps the patient to arrive at an appropriate decision.

REPORTING PATIENTS TO GOVERNMENT AUTHORITIES

What should the role of the practitioner be in the contentious issue of reporting unsafe drivers to a public health authority? Currently there are 6 states that have mandatory reporting laws of any unsafe driver for any pathology that can impair driving function (table 3).7,8 These 6 states include California, Oregon, Nevada, New Jersey, Delaware, and Pennsylvania. Moreover, California and Oregon have specific reporting laws for dementia to government authorities. The AAN addressed the issue of mandatory physician reporting of medical conditions that may affect driving competence in 2007.11 In their official statement, the AAN supports the optional reporting of individuals with medical conditions that may affect one's ability to drive safely, especially in cases where public safety has already been compromised or it is clear that the person no longer has the skills needed to drive safely. Further details on the AAN position can be found in reference11. However, there are several concerns that need to be addressed regarding reporting, particularly involving trust between physician and patient. In states where mandatory reporting is not required, there is little protection for the physician who chooses to report out of concerns for public safety. Perhaps anonymous reporting or legal protection of the reporting physician could help the situation as concerns over the potential for litigation likely leads to underreporting to authorities.

Driving and Neurological Disorders

  • Motor vehicle accidents are a major cause of injury, mortality, and financial damage.

  • Many neurologic conditions impair driving capability.

  • Degree of deficit, frequency, and type of events determine driving fitness.

  • Reporting drivers: Know the laws in your state.

  • AAN has Practice Parameters for driving in patients with dementia.

DISCUSSION

The decision to drive or not depends on the individual facts of the case. There are no easy answers as to exactly when driving should be terminated. Neurologists would be well-served by understanding applicable driving laws and factors that affect driving, clearly documenting telephone conversations and consultations when driving is discussed, and periodically revisiting the topic to maximize safety and improve quality of life.

DISCLOSURE

Dr. Drazkowski receives research support from NeuroVista Corporation. Dr. Sirven serves on the editorial board of Epilepsy.com; receives royalties from the publication of Clinical Neurology of the Older Adult (Lippincott Williams & Wilkins, 2008) and UpToDate, Inc. (2010); and receives research support from the NIH/NINDS.

  • Received October 13, 2010.
  • Accepted December 16, 2010.
  • Copyright © 2011 by AAN Enterprises, Inc.

REFERENCES

  1. 1.↵
    National Center on Sleep Disorders Research/National Highway Traffic Safety Administration Expert Panel on Driver Fatigue and Sleepiness. Drowsy driving and automobile crashes. Available at: http://www.nhtsa.gov/people/injury/drowsy_driving1/drowsy.html. Accessed October 12, 2010.
  2. 2.↵
    1. Uc E,
    2. Rizzo M
    . Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 2008;8:377–383.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Drachman D,
    2. Swearer J
    . Driving and Alzheimer's disease: the risk of crashes. Neurology 1993;43:2448–2456.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Dubinsky R,
    2. Stein A,
    3. Lyons K
    . Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): Report of the Quality Standards subcommittee of the AAN. Neurology 2000;54:2205–2211.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Iverson D,
    2. Gronseth G,
    3. Reger M,
    4. et al
    . Practice parameter update: evaluation and management of driving risk in dementia. Neurology 2010;74:1316–1324.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Gilliam F,
    2. Kuzniecky R,
    3. Faught E,
    4. Black L,
    5. Carpenter G
    . Patient validated content of epilepsy specific quality of life measurements. Epilepsia 1997;38:233–236.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Driving regulations. Available at: http://www.epilepsyfoundation.org/living/wellness/transportation/drivinglaws.cfm. Accessed October 12, 2010.
  8. 8.↵
    The impaired driver. Available at: http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/opinion224.shtml. Accessed December 1, 2010.
  9. 9.↵
    1. Drazkowski J,
    2. Fisher R,
    3. Sirven J,
    4. Demaerschalk B,
    5. Uber-Zak L,
    6. Hentz J
    . Seizure related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc 2003;78:819–825.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Drazkowski JF,
    2. Neiman E,
    3. Sirven J,
    4. McAbee G,
    5. Noe K
    . Frequency of physician counseling and attitudes toward driving motor vehicles in people with epilepsy: comparing a mandatory reporting with a voluntary reporting state. Epilepsy Behav 2010;19:52–54.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Morris J,
    2. Mateen F,
    3. Fisher R,
    4. et al
    . AAN position statement on physician reporting of medical conditions that may affect driving competence: to drive or not to drive: roles of the physician, patient and state. Neurology 2007;69:1958–1959.
    OpenUrlFREE Full Text

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • THE NEUROLOGY OF DRIVING
    • FIXED DEFICIT DISORDERS: AD
    • PAROXYSMAL CONDITIONS: EPILEPSY
    • COUNSELING A NEUROLOGY PATIENT REGARDING DRIVING
    • REPORTING PATIENTS TO GOVERNMENT AUTHORITIES
    • DISCUSSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Epilepsy/Seizures
  • All Neuropsychology/Behavior
  • Alzheimer's disease
  • Parkinson's disease/Parkinsonism
  • Patient safety

Alert Me

  • Alert me when eletters are published
Neurology: 100 (6)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise